https://orcid.org/0000-0002-2613-9364
References
- Centers for Disease Control and Prevention. Antibiotic/Antimicrobial Resistance (AR/AMR). https://www.cdc.gov/drugresistance/index.html. Accessed 10/22/2020.
- Dellit TH, Owens RC, McGowan JE, Jr., Society for Healthcare Epidemiology of America, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.
- Heikkila AM. Antibiotics in pregnancy – a prospective cohort study on the policy of antibiotic prescription. Ann Med. 1993;25(5):467–471.
- Bookstaver PB, Bland CM, Griffin B, et al. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015;35(11):1052–1062.
- Jamie WE, Edwards RK, Duff P. Antimicrobial susceptibility of Gram-negative uropathogens isolated from obstetric patients. Infect Dis Obstet Gynecol. 2002;10(3):123–126.
- Duff P. Pyelonephritis in pregnancy. Clin Obstet Gynecol. 1984;27(1):17–31.
- Plante LA, Pacheco LD, Louis JM. SMFM consult series #47: Sepsis during pregnancy and the puerperium. Am J Obstet Gynecol. 2019;220(4):B2–B10.
- Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
- Hart A, Nowicki BJ, Reisner B, et al. Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis. 2001;183(10):1526–1529.
- Greer LG, Roberts SW, Sheffield JS, et al. Ampicillin resistance and outcome differences in acute antepartum pyelonephritis. Infect Dis Obstet Gynecol. 2008;2008:891426.
- Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990–1001.
- Medicare and Medicaid Programs; Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction; Fire Safety Requirements for Certain Dialysis Facilities; Hospital and Critical Access Hospital (CAH) Changes To Promote Innovation, Flexibility, and Improvement in Patient Care. https://www.federalregister.gov/documents/2019/09/30/2019-20736/medicare-and-medicaid-programs-regulatory-provisions-to-promote-program-efficiency-transparency-and.
- Centers for Disease Control and Prevention. Core elements of hospital antibiotic stewardship programs. https://www.cdc.gov/antibiotic-use/core-elements/hospital.html. Accessed 10/22/2020.
- Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis. 2007;44(6):867–873.
- Gray KL, Fulcher LC, McElmeel ML, et al. The outpatient institutional antibiogram does not accurately reflect the susceptibility of prepartum group B streptococcal isolates to erythromycin and clindamycin. Diagn Microbiol Infect Dis. 2011;71(4):457–459.
- CLSI. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline-fourth edition. In CLSI document M39-A4. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
- American College of Obstetrics and Gynecologists. ACOG Practice Bulletin No. 91: treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111(3):785–794.
- Vazquez JC, Abalos E. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev. 2011;(1):CD002256.
- Grech A, Collins CE, Holmes A, et al. Maternal exposures and the infant gut microbiome: a systematic review with meta-analysis. Gut Microbes. 2021;13(1):1–30.
- Nyangahu DD, Lennard KS, Brown BP, et al. Disruption of maternal gut microbiota during gestation alters offspring microbiota and immunity. Microbiome. 2018;6(1):124.
- Tormo-Badia N, Hakansson A, Vasudevan K, et al. Antibiotic treatment of pregnant non-obese diabetic mice leads to altered gut microbiota and intestinal immunological changes in the offspring. Scand J Immunol. 2014;80(4):250–260.